Register or Sign in
to unlock feature

you are not authorized to read this article.

Login or register your account to get full access to the tableting technology platform.

Login Register
Please verify your account
Please confirm your email address to validate your registration. Follow the link on email received to verify your email adress.
Re-send verification email
Please complete your registration
You're logged in but you didn't complete your registration.
Complete my registration
Exclusive content

You are not authorized to read this article.

mystylone subscription is required to view this content.

Login Register
Close search
  • Resources
  • Products & Services
    • Compaction Simulators
    • R&D / Process Support
  • Events
  • About
  • Contact Us
  • Sign in
Resources
  1. Home /
  2. Resources /
  3. Newsfeeds /
  4. Optimizing pediatric product development for commercialization success
NEWSFEEDS

Optimizing pediatric product development for commercialization success

July 08, 2025
Remove from favorites
Add to favorites

Ensuring medication adherence in children is challenging due to their changing physiology from infancy to adolescence, which complicates drug formulation. Pediatric formulations must offer flexible, accurate dosing, be easy to swallow, and taste acceptable. Multiparticulate systems (like granules, minitabs, or beads) are especially effective, allowing tailored dosing and administration via various formats (e.g., ODTs, sprinkles, suspensions).

This presentation explores the importance of pediatric-specific drug development, regulatory requirements, and formulation strategies—highlighting multiparticulates as a versatile solution.

Key learning objectives:

- Understand the importance of pediatric populations and the related regulatory landscape
- Identify age-specific dosing needs to improve acceptance and adherence
- Explore multiparticulates as an adaptable platform for pediatric formulations

Read more
Optimizing Pediatric Product Development For Commercialization Success - image
pediatric drug delivery multiparticulate drug delivery system
Contributor(s):
Share Copied!
Comments

No comments posted yet.

Add a comment

Articles you may like

no-image

Understanding the factors that control the quality of mini-tablet compression: flow, particle size, and tooling dimension

first_published_at:April 1, 2018, midnight / date_published:April 1, 2018
Papers - 01/04/2018 - by Junshu Zhao, David Yin, Jasmine Rowe, Sherif Badawy, Faranak Nikfar, Preetanshu Pandey
Despite the growing significance of mini-tablets for their advantages in pediatric formulations and modified-release applications, their widespread use is hindered by the limited knowledge of formulation and processing techniques required …

Tablet and mini tablets

Development and evaluation of sustained-release Compritol ® 888 ATO matrix mini-tablets

first_published_at:Sept. 1, 2012, midnight / date_published:Sept. 1, 2012
Papers - 01/09/2012 - by Matthew Roberts, Daniele Vellucci, Shabbir Mostafa, Cedric Miolane, Delphine Marchaud
Context: Sustained-release mini-tablets hold promise for pediatric drug delivery and as multiparticulate dosage forms. Objective: Assess the feasibility of developing lipophilic matrix mini-tablets and examine the impact of Compritol® 888 …

Timeline of US and EU regulations impacting pediatric therapies

Combining patient centricity and commercial viability in pediatric product development

first_published_at:Nov. 14, 2024, 5:12 p.m. / date_published:None
Newsfeeds - 14/11/2024 -
In pediatric drug formulation, achieving patient adherence and acceptance is crucial due to children’s rapid development and unique pharmacokinetic profiles. Pediatric formulations face specific challenges, including complex regulations, formulation demands, …

More

Related products

Take_off_sensor

Linear ejection device

MEDELPHARM
Introducing the linear ejection device, a versatile accessory designed to seamlessly integrate with the STYL'One …
Accessory_Evo_TabInTab_16

Tab-in-tab device

MEDELPHARM
Tab-in-tab technology (press-coated tablets) showcases multiple advantages including enhanced drug stability, modified release profiles, taste …
Accessory_Evo_gravity_feeder_3

Gravity feeder - STYL'One Evo

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
Tapping Feeder - STYL'One Evo 4

Tapping feeder - STYL'One Evo

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
Paddle Force Feeder - STYL'One Nano 1

Paddle force feeder - STYL'One Nano

MEDELPHARM
The primary function of compaction simulators is to provide reliable data from which information can …
illustration STYL'One Mist manual lubrication

Manual external lubrication

MEDELPHARM
In development, external lubrication enables the characterization of the compaction behavior of pure APIs or …
Evolution_resize

STYL'One Evo

MEDELPHARM
The STYL’One Evo is a highly versatile compaction simulator designed to support pharmaceutical and nutraceutical …
0.STYLOne_Nano_y66g4Pc_resize

STYL'One Nano

MEDELPHARM
The STYL’One Nano is a compact, benchtop compaction simulator designed for early-stage tablet formulation and …
STYLOne_EVO_OEB3_sans_fond_mod_resize

STYL'One Evo DryCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
STYLONE_EVO_OEB5_transparent_apxkk5N_resize

STYL'One Evo WipCon®

MEDELPHARM
The STYL’One Evo is designed to work under negative pressure and as such, the standard …
laptop laboratory gloves

Looking for additional information?

Let us help you

Contact our experts

GENERAL

  • Terms of service
  • Privacy Policy
  • Cookie Policy
  • About
  • Contact us

Account

  • Login

Follow us on

© 2025 Medelpharm